BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16802209)

  • 1. Screening of compactin-resistant microorganisms capable of converting compactin to pravastatin.
    Chen CH; Hu HY; Cho YC; Hsu WH
    Curr Microbiol; 2006 Aug; 53(2):108-12. PubMed ID: 16802209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioconversion of compactin into pravastatin by Streptomyces sp.
    Park JW; Lee JK; Kwon TJ; Yi DH; Kim YJ; Moon SH; Suh HH; Kang SM; Park YI
    Biotechnol Lett; 2003 Nov; 25(21):1827-31. PubMed ID: 14677706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxylation of Compactin (ML-236B) by CYP105D7 (SAV_7469) from
    Yao Q; Ma L; Liu L; Ikeda H; Fushinobu S; Li S; Xu LH
    J Microbiol Biotechnol; 2017 May; 27(5):956-964. PubMed ID: 28274099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient bioconversion of compactin to pravastatin by the quinoline-degrading microorganism Pseudonocardia carboxydivorans isolated from petroleum-contaminated soil.
    Lin CL; Tang YL; Lin SM
    Bioresour Technol; 2011 Nov; 102(22):10187-93. PubMed ID: 21974888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biotransformation of compactin to pravastatin by Actinomadura sp. 2966.
    Peng Y; Yashphe J; Demain AL
    J Antibiot (Tokyo); 1997 Dec; 50(12):1032-5. PubMed ID: 9510910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a novel expression vector in Pseudonocardia autotrophica and its application to efficient biotransformation of compactin to pravastatin, a specific HMG-CoA reductase inhibitor.
    Fujii Y; Norihisa K; Fujii T; Aritoku Y; Kagawa Y; Sallam KI; Johdo O; Arisawa A; Tamura T
    Biochem Biophys Res Commun; 2011 Jan; 404(1):511-6. PubMed ID: 21144838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial hydroxylation of ML-236B (compactin). Studies on microorganisms capable of 3 beta-hydroxylation of ML-236B.
    Serizawa N; Serizawa S; Nakagawa K; Furuya K; Okazaki T; Terahara A
    J Antibiot (Tokyo); 1983 Jul; 36(7):887-91. PubMed ID: 6684108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of cytochrome P-450sca from Streptomyces carbophilus. ML-236B (compactin) induces a cytochrome P-450sca in Streptomyces carbophilus that hydroxylates ML-236B to pravastatin sodium (CS-514), a tissue-selective inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase.
    Matsuoka T; Miyakoshi S; Tanzawa K; Nakahara K; Hosobuchi M; Serizawa N
    Eur J Biochem; 1989 Oct; 184(3):707-13. PubMed ID: 2509201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxonomy of actinomycetes capable of hydroxylation of ML-236B (compactin).
    Okazaki T; Serizawa N; Enokita R; Torikata A; Terahara A
    J Antibiot (Tokyo); 1983 Sep; 36(9):1176-83. PubMed ID: 6630076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum.
    McLean KJ; Hans M; Meijrink B; van Scheppingen WB; Vollebregt A; Tee KL; van der Laan JM; Leys D; Munro AW; van den Berg MA
    Proc Natl Acad Sci U S A; 2015 Mar; 112(9):2847-52. PubMed ID: 25691737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification of Streptomyces strain Z314 and purification of its product pravastatin].
    Zhang L; Zhang J; Yang W; Bai G
    Wei Sheng Wu Xue Bao; 2008 Jan; 48(1):33-7. PubMed ID: 18338573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein engineering of CYP105s for their industrial uses.
    Yasuda K; Sugimoto H; Hayashi K; Takita T; Yasukawa K; Ohta M; Kamakura M; Ikushiro S; Shiro Y; Sakaki T
    Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):23-31. PubMed ID: 28583351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strain Improvement of Streptomyces xanthochromogenes RIA 1098 for Enhanced Pravastatin Production at High Compactin Concentrations.
    Dzhavakhiya VV; Voinova TM; Glagoleva EV; Petukhov DV; Ovchinnikov AI; Kartashov MI; Kuznetsov BB; Skryabin KG
    Indian J Microbiol; 2015 Dec; 55(4):440-6. PubMed ID: 26543270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
    Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S
    Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biotechnological production and applications of statins.
    Barrios-González J; Miranda RU
    Appl Microbiol Biotechnol; 2010 Jan; 85(4):869-83. PubMed ID: 19820926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tracing the past half century of my microbial transformation studies].
    Naito A
    Yakugaku Zasshi; 2000 Oct; 120(10):839-48. PubMed ID: 11082697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of dihydroxy derivative of ML-236B from ML-236B (compactin) by lipid peroxidation.
    Serizawa N; Nakahara K; Matsuoka T
    J Antibiot (Tokyo); 1990 Aug; 43(8):1031-3. PubMed ID: 2120167
    [No Abstract]   [Full Text] [Related]  

  • 18. Compactin production studies using Penicillium brevicompactum under solid-state fermentation conditions.
    Shaligram NS; Singh SK; Singhal RS; Pandey A; Szakacs G
    Appl Biochem Biotechnol; 2009 Nov; 159(2):505-20. PubMed ID: 19099208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compactin-a review.
    Chakravarti R; Sahai V
    Appl Microbiol Biotechnol; 2004 Jun; 64(5):618-24. PubMed ID: 15034683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of computer to monitoring and control of fermentation process: Microbial conversion of ML-236B Na to pravastatin.
    Hosobuchi M; Kurosawa K; Yoshikawa H
    Biotechnol Bioeng; 1993 Sep; 42(7):815-20. PubMed ID: 18613128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.